Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 3/20 | 0.64 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | CNR2 | P34972 | 10/20 | 0.49 |
| ▸ | TNF | P01375 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8959942 | 0.90 | CNR1 (0.71) | CNR1CREBBPLMNACNR2TNF | |
| SCHEMBL8959790 | 0.86 | CNR1 (0.66) | CNR1CREBBPLMNACNR2 | |
| SCHEMBL8959933 | 0.86 | CNR1 (0.66) | CNR1CREBBPLMNACNR2 | |
| SCHEMBL8959736 | 0.86 | CNR1 (0.66) | CNR1CREBBPLMNACNR2 | |
| SCHEMBL8959991 | 0.86 | CNR1 (0.66) | CNR1CREBBPLMNACNR2 | |
| SCHEMBL8959776 | 0.86 | CNR1 (0.66) | CNR1CREBBPLMNACNR2 | |
| SCHEMBL8959670 | 0.86 | CNR1 (0.66) | CNR1CREBBPLMNACNR2 | |
| SCHEMBL8959828 | 0.86 | CNR1 (0.66) | CNR1CREBBPLMNACNR2 | |
| SCHEMBL8959768 | 0.85 | CNR1 (0.60) | CNR1CREBBPLMNACNR2 | |
| SCHEMBL8959919 | 0.85 | CREBBP (0.57) | CREBBPCNR2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5530019-A | FOR TREATMENT OF PROSTATE GLAND DISORDERS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-06-25 | — | — | US | disclosed |